<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01447160</url>
  </required_header>
  <id_info>
    <org_study_id>FUSao Paulo</org_study_id>
    <nct_id>NCT01447160</nct_id>
  </id_info>
  <brief_title>Effectiveness of Facet Joint Infiltration in Low Back Pain</brief_title>
  <official_title>Effectiveness of Facet Joint Infiltration in Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of facet joint infiltration with&#xD;
      corticosteroids in the treatment of low back pain due to facet joint osteoarthritis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sixty subjects with diagnostic of facet joint syndrome will be enrolled in the study.&#xD;
&#xD;
      They were randomized into experimental and control groups. The experimental group will be&#xD;
      submitted to intra-articular infiltration of six facet joints. The control group will be&#xD;
      submitted to intramuscular injection of six lumbar paravertebral points. After the&#xD;
      randomization, all subjects will be assessed by an investigator blinded to the groups. The&#xD;
      assessment will be taken just before the interventions (T0) and them 7 , 30 , 90 and 180 days&#xD;
      after the interventions. The following assessment instruments will be used: pain visual&#xD;
      analogical scale (VAS) (0-10cm), pain visual analogical scale during extension of the spine&#xD;
      (VAS E) (0-10cm), Likert scale for improving (0-5), percentage scale of subjective improving&#xD;
      perception(0-100%), Rolland-Morris questionnaire (0-24), short health survey questionnaire&#xD;
      (SF36), accountability of medications taken for back pain: analgesics and non-steroidal&#xD;
      antiinflammatories (NSAIDs).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">April 2012</completion_date>
  <primary_completion_date type="Anticipated">April 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain visual analogic scale</measure>
    <time_frame>baseline</time_frame>
    <description>pain visual scale graduated from zero to ten</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain visual analogic scale</measure>
    <time_frame>4 weeks</time_frame>
    <description>pain visual analogic scale graduated 0--10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain visual analogic scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>pain visual analogic scale graduated 0--10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain visual analogic scale</measure>
    <time_frame>24 weeks</time_frame>
    <description>pain visual analogic scale graduated 0--10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rolland Morris questionnaire</measure>
    <time_frame>baseline</time_frame>
    <description>assess functional capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rolland Morris questionnaire</measure>
    <time_frame>4 weeks</time_frame>
    <description>assess functional capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rolland Morris questionnaire</measure>
    <time_frame>12 weeks</time_frame>
    <description>assess functional capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rolland Morris questionnaire</measure>
    <time_frame>24 weeks</time_frame>
    <description>assess functional capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>baseline</time_frame>
    <description>assess quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>4 weeks</time_frame>
    <description>assess quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>12 weeks</time_frame>
    <description>assess quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>24 weeks</time_frame>
    <description>assess quality of life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>facet joint infiltration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group will be submitted to intra-articular infiltration of six facet joints (L3/L4;L4/L5;L5/S1 bilaterally) with triamcinolone hexacetonide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intramuscular injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group which were submitted to triamcinolone acetonide intramuscular injection of six lumbar paravertebral points</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cortisone</intervention_name>
    <description>intraarticular infiltration with 1ml of triamcinolone hexacetonide versus intramuscular injection with 1 ml of triamcinolone acetonide</description>
    <arm_group_label>facet joint infiltration</arm_group_label>
    <arm_group_label>intramuscular injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  low back pain up to 3 months&#xD;
&#xD;
          -  pain on back extension&#xD;
&#xD;
          -  radiologic findings of facet joint osteoarthritis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  other causes of back pain&#xD;
&#xD;
          -  fibromyalgia&#xD;
&#xD;
          -  diabetes, arterial hypertension or glaucoma not well controlled&#xD;
&#xD;
          -  patients with contrast allergy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luiza Ribeiro, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sao Paulo Federal University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>luiza ribeiro, doctor</last_name>
    <phone>55-11 92678027</phone>
    <email>luizahcr@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sao Paulo federal University</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>04023-062</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <investigator>
      <last_name>Luiza Ribeiro, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <study_first_submitted>July 29, 2011</study_first_submitted>
  <study_first_submitted_qc>October 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2011</study_first_posted>
  <last_update_submitted>October 5, 2011</last_update_submitted>
  <last_update_submitted_qc>October 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Federal University os Sao Paulo</name_title>
    <organization>Federal University of São Paulo</organization>
  </responsible_party>
  <keyword>facet joint</keyword>
  <keyword>back pain</keyword>
  <keyword>osteoarthritis</keyword>
  <keyword>infiltration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cortisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

